Xingneng Xuanguang, a rising Chinese private commercial fusion company, has announced the completion of two rounds of Series A funding totalling CNY500m ($73.8m). New investors included Jinpu Investment, Dachen Capital, Cornerstone Capital, Honghui Fund, Shilin Group and Shanghai Science and Technology Innovation Group (part of Shanghai State-owned Investment Group). Existing shareholders such as Ant Group, Zhongke Chuangxing, Xin Capital, Dinghe Gaoda, Jinyu Maowu, Beyond Times, Hefei Angel Investment Fund (part of Hefei Industrial Investment) and Tianchuang Capital continued to invest.
Xingneng Xuanguang is steadily advancing its X Series pulse compression Field-Reversed Configuration (FRC) validation device. By securing a successful round of private capital funding, the firm is transitioning from its initial proof-of-concept phase to a highly optimised, high-performance experimental setup.
The validation strategy relies on the success of the company’s baseline “Flame” installation. The primary role of the Flame device was to confirm that the FRC plasma configuration could be reliably formed, translated, and initially compressed. With that baseline engineering validated, the company is focusing on scaling up performance metrics via systematic hardware overhauls.
To transform the X Series into a strict validation platform for commercial fusion parameters, upgrades are being integrated across three core technology pillars:
- Advanced Heating Systems – increasing auxiliary power injection via enhanced magnetic compression and radiofrequency/neutral beam injection to aggressively raise core plasma temperatures.
- High-Fidelity Diagnostics – deploying faster, radiation-hardened diagnostic arrays to map real-time structural shifts in the FRC, providing clear validation data regarding density profiles.
- Plasma Control Systems – refining magnetic field topologies and feedback loops to suppress hydrodynamic instabilities, directly extending plasma density and retention (confinement) time.
Xingneng Xuanguang’s rapid scaling mirrors a larger trend in the global and domestic fusion market, where private enterprises are leveraging agile engineering cycles. Private capital investments in both the US and China have surged driving alternatives to traditional Tokamak designs like FRCs and spherical toruses toward commercial
Xingneng Xuanguang is an advanced technology company, established with the support of the China University of Science and Technology (USTC), specialising in the development of high-performance field-inversion fusion prototypes and advancing the development of compact and low-cost fusion facilities.
The company’s founder, Professor Sun Xuan, heads KMAX, China’s first field-inversion fusion facility. He has nearly 30 years of research experience in the field, including extensive experience working on renowned facilities such as TAE C2 and FRX-L. The core team consists of USTC professors and PhDs, with doctoral students making up more than 40% of the team.
As a pioneer in China’s resonance fusion (FRC) technology, Xingneng Xuanguang is at the forefront of device building and experimental practice. In February 2025, Xingneng Xuanguang’s first FRC pulsed experimental device, the Xeonova-1, reached plasma discharge, with less than two months from on-site installation to successful discharge, setting a new record for the construction speed of Chinese fusion facilities. In January, FLAME’s advanced anti-magnetic mirror fusion device reached the first plasma discharge, marking the official transition of Xingneng Xuanguang to the physical experimentation phase.
